Pricing Log in Create free account

Phathom Pharmaceuticals, Inc. (PHAT) vs PureTech Health PLC Sponsored ADR (PRTCY)

Phathom Pharmaceuticals, Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Phathom Pharmaceuticals, Inc. and PureTech Health PLC Sponsored ADR are of similar size ($424.0M and $413.0M). Phathom Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 86.8% against 28.5%. Phathom Pharmaceuticals, Inc. has the higher net margin (−30.2% vs −199.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Phathom Pharmaceuticals, Inc. leads on 7 and PureTech Health PLC Sponsored ADR on 7.

Valuation

Metric PHAT PRTCY Biotechnology median
P/E n/m n/m 10.60
P/S 1.62 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.81 0.66
EV/Sales 1.58 (9.10) 9.02
Earnings yield (19.76%) (1.32%) (32.88%)
Free cash flow yield (4.74%) 0.00% (23.13%)

Profitability

Metric PHAT PRTCY Biotechnology median
Gross margin 80.68% 0.00% 68.51%
Operating margin (9.26%) 0.00% 0.00%
Net margin (30.19%) (199.36%) 0.00%
Free cash flow margin (7.65%) 0.00% 0.00%
Return on equity 21.55% 0.00% (51.96%)
Return on assets (28.36%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHAT PRTCY Biotechnology median
Revenue growth (TTM) 86.75% 28.48% 6.76%
EPS growth (last fiscal year) 42.72% (318.75%) 29.88%
Revenue growth, 5-year CAGR — (16.92%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHAT PRTCY Biotechnology median
Debt to equity (0.48) 0.00 0.00
Current ratio 1.76 6.59 4.97
Net debt to EBITDA (0.51) 3.03 1.01

Dividend

Metric PHAT PRTCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PHAT PRTCY Biotechnology median
Market cap 412.96m 424.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack